Human Cell Atlas

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements

Retrieved on: 
Tuesday, April 9, 2024
Shenzhen University, Molecular biology, Immunology, Nature Methods, Advanced technology, Proteome, Ageing, Speech, Genesis (journal), Data analysis, Southern Medical University, Neuroscience, Translation, Human Cell Atlas, Nature Communications, Biochemistry, Neurology, Communication, Transcriptome, Genetics, Research, Genome, Epigenome, Immunity, Microbiology, Metabolome, Diagnosis, Peking University, Health, Conference, GSA, Executive, Cancer, Fudan University, Reproduction, Biology, National academy, Zhejiang University, Medicine

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.

Key Points: 
  • SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.
  • With the theme "Technologic Innovation, Scientific Discovery, Translational Application", TICSSO-2 focused on the latest advances in single-cell and spatial omics.
  • On March 31st and April 1st were four online international forums, with one specifically for young researchers.
  • TICSSO-2 is hailed as the largest, most influential, and highest academic conference in the field of single-cell and spatial omics in the world.

What makes us human? Detailed cellular maps of the entire human brain reveal clues

Retrieved on: 
Thursday, October 12, 2023
Neuroscience, Knowledge, Senior, 3D, Allen Institute, Brain, Neocortex, Cell, Neuron, Chimpanzee, BRAIN, Epilepsy, Myenteric plexus, Neurosurgery, Karolinska Institute, Patient, Visual cortex, Human Cell Atlas, Allen Institute for Brain Science, BRAIN Initiative, Primate, Gene, Research, Molecular biology, Catalog, Mouse, Bangladesh Technical Education Board, Science Advances, Tissue, Human, Genomics, Science Translational Medicine, Mammal, NIH, Mobile phone, Medical imaging, Truffle, Science

SEATTLE, Oct. 12, 2023 /PRNewswire/ -- Scientists have just unveiled a massive effort to understand our own brains and those of our closest primate relatives.

Key Points: 
  • It's a huge leap from previously published work, with studies and data that reveal new insights about our nervous systems' cellular makeup across many regions of the brain and what is distinctive about the human brain.
  • It was brought together and is funded by the National Institutes of Health's Brain Research Through Advancing Innovative Neurotechnologies ® (BRAIN) Initiative.
  • Where the single region studies found over 100 different brain cell types, the newly released data shows thousands of different kinds of brain cells across the entire brain.
  • This was one of the first human brain studies to compare a large number of individual people using single-cell techniques.

CS Genetics Appoints Mike Stubbington, PhD, as Vice President of Research and Development

Retrieved on: 
Tuesday, July 11, 2023
Operation, Natural science, University, Senior, Genomics, Human Cell Atlas, Wellcome Sanger Institute, Innovation system, European Bioinformatics Institute, Master of Science, Doctor of Philosophy, Research and development, Genetics, SAN, HCA, Biology, Synteny, R, Health, BEAM, Disease, Vaccine, Molecular biology, Research

SAN DIEGO and CAMBRIDGE, England , July 11, 2023 /PRNewswire/ -- CS Genetics, a privately held genomics-technology company, today announced the appointment of Mike Stubbington, PhD, as Vice President of Research and Development.

Key Points: 
  • SAN DIEGO and CAMBRIDGE, England , July 11, 2023 /PRNewswire/ -- CS Genetics , a privately held genomics-technology company, today announced the appointment of Mike Stubbington, PhD, as Vice President of Research and Development.
  • Mike joins CS Genetics with a decade of experience in the development and application of single-cell technologies.
  • "I am delighted to welcome Mike to our team at CS Genetics and turn over leadership of our Cambridge-based R&D team to him.
  • I'm looking forward to leading the R&D team to further success and delivering their ambitious roadmap of new single-cell products to the research community," said Mike Stubbington, Vice President of R&D at CS Genetics.

Mary Kay Inc. & European Society for Dermatological Research Partner to Award Educational Research Grants Advancing Skin Health/Skin Disease

Retrieved on: 
Wednesday, May 17, 2023
Cosmetics, Men, Retail, Health, Consumer, Lifestyle, Oncology, Research, Infectious Diseases, General Health, Genetics, Fitness & Nutrition, Science, Women, Human, Society, Partnership, Skin care, ETH, Human Cell Atlas, Skin, Dermatology, Skin cancer, Cancer, ESDR, Multimedia, Regenerative medicine, Assistant professor, Vivo, Tissue Engineering and Regenerative Medicine International Society, Mary Kay, Gene therapy, ISCB Senior Scientist Award, Biology, European Society for Clinical Investigation, Carcinoma, BCC, Tumor microenvironment, Conference, Pharmaceutical industry

Mary Kay Inc. , a global leader in skin care innovation, in partnership with the European Society for Dermatological Research , recently announced its inaugural Mary Kay Skin Health/Skin Disease Research Grant awardees at a special virtual event prior to the First International Societies for Investigative Dermatology conference in May.

Key Points: 
  • Mary Kay Inc. , a global leader in skin care innovation, in partnership with the European Society for Dermatological Research , recently announced its inaugural Mary Kay Skin Health/Skin Disease Research Grant awardees at a special virtual event prior to the First International Societies for Investigative Dermatology conference in May.
  • View the full release here: https://www.businesswire.com/news/home/20230517005040/en/
    Mary Kay partnered with European Society for Dermatological Research (ESDR) to award inaugural Mary Kay-ESDR Skin Health/Skin Disease Research Grants.
  • Congratulations to our 2022 recipients, Dr. Clarisse Ganier and Dr. Michael Cangkrama, who will each receive $20,000 grants to further their contributions in skin disease research.
  • (Photo: Mary Kay Inc.)
    “Mary Kay is dedicated to advancing skin and nutritional health research globally, and we know this cannot be done alone.

Parse Biosciences and Human Cell Atlas Partner to Help Map Human Cells

Retrieved on: 
Thursday, April 27, 2023
Human Cell Atlas, Wellcome Sanger Institute, Human body, Genetics, Health, Partnership, Research, HCA, Pharmaceutical industry, Vaccine

SEATTLE, April 27, 2023 /PRNewswire-PRWeb/ -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the company has partnered with the international Human Cell Atlas (HCA) consortium, a global collaboration of researchers developing comprehensive reference maps of all human cells as a basis for understanding human health and diagnosing, monitoring, and treating disease.

Key Points: 
  • SEATTLE, April 27, 2023 /PRNewswire-PRWeb/ -- Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the company has partnered with the international Human Cell Atlas (HCA) consortium, a global collaboration of researchers developing comprehensive reference maps of all human cells as a basis for understanding human health and diagnosing, monitoring, and treating disease.
  • Parse's EvercodeTM technology for single cell transcriptomics and single cell immune profiling enables million-cell experiments without the need for expensive instrumentation.
  • Parse will also provide support to HCA members for experimental design, assay execution, and bioinformatic support in applying the Evercode technology to their research.
  • "The Human Cell Atlas project is an enormous undertaking and will transform our understanding of the 37 trillion cells in the human body," noted Dr Sarah Teichmann, co-Chair of the HCA Organizing Committee and Head of Cellular Genetics at England's Wellcome Sanger Institute.

Pixelgen Technologies Launches to Advance Single-Cell Spatial Proteomics

Retrieved on: 
Wednesday, December 7, 2022
Gene expression, Entrepreneurship, Human Protein Atlas, Investment, Protein, Drug discovery, Thermo Fisher Scientific, DNA, Human Cell Atlas, Biology, Genomics, Stanford University, QIAGEN, Map, Cell, Marketing, United States Air Force Scientific Advisory Board, Proteomics, Life Technologies, Microscope, Management, Fredriksson

STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Pixelgen Technologies emerged from stealth today with a mission to bring a new dimension to single-cell spatial proteomics. The launch follows the close of an approximate $6 million seed round, led by Navigare Ventures, which will support the commercialization next year of the company's groundbreaking Molecular Pixelation technology for spatial analyses of cell surface proteins in 3D.

Key Points: 
  • STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Pixelgen Technologies emerged from stealth today with a mission to bring a new dimension to single-cell spatial proteomics.
  • Yet, cell function and activity are primarily governed by the spatial orchestration of cell surface proteins, particularly immune cells.
  • Understanding cellular activity through the spatial organization of proteins remains largely uncharted because current tools cannot identify many proteins simultaneously and map their spatial inter-relationships.
  • Molecular Pixelation is the only technology able to show spatial protein polarization and co-localization on the cell surface in a highly multiplexed manner.

IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library

Retrieved on: 
Monday, January 10, 2022
Health, SEC, Proteome, Growth, Regulation, The Scientist (magazine), Human Cell Atlas, Security (finance), Industry, Systems biology, NASDAQ, U.S. Securities and Exchange Commission, Human body, Forward-looking statement, Cell, HIV disease progression rates, Private Securities Litigation Reform Act, Neurology, University of Washington firebombing incident, University, Medicine, COVID-19, Infection, Isoplexis, Inflammation, GLOBE, Institute, Biological engineering, Fine chemical, Vaccine, Risk management, Fierce

BRANFORD, Conn., Jan. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ:ISO), the Superhuman Cell Company, today announcedits preliminary unaudited revenue for the full year 2021.

Key Points: 
  • BRANFORD, Conn., Jan. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ:ISO), the Superhuman Cell Company, today announcedits preliminary unaudited revenue for the full year 2021.
  • Since the commercial launch in 2018, Isoplexis has placed 209 total instruments, including 98 new instruments sold during 2021.
  • IsoPlexis also today unveiled The Superhuman Cell Library, an industry-first mapping of the proteomically driven cells, unique to IsoPlexis platform, that determine how the human body responds to complex disease.
  • Our 2021 revenue growth reinforces the value of our platform and how, together with the release of The Superhuman Cell Library, IsoPlexis is taking a lead in advancing the future of medicine and health, said IsoPlexis Chief Executive Officer Sean Mackay.

Akoya to Help Support the Human Cell Atlas (HCA) Initiative with Single-Cell, Spatial Imaging Capabilities

Retrieved on: 
Tuesday, March 23, 2021
Oncology, Health, Genetics, Research, Science, Pharmaceutical, Biotechnology, Biological databases, Online databases, Proteomics, Human Cell Atlas, Akoya, Human Protein Atlas

Akoya Biosciences, Inc., The Spatial Biology Company, today announced its support for the Human Cell Atlas (HCA) initiative, offering the CODEX solutions single-cell, whole-tissue imaging capabilities to HCA members under favorable commercial terms.

Key Points: 
  • Akoya Biosciences, Inc., The Spatial Biology Company, today announced its support for the Human Cell Atlas (HCA) initiative, offering the CODEX solutions single-cell, whole-tissue imaging capabilities to HCA members under favorable commercial terms.
  • The mission of the Human Cell Atlas is to create comprehensive reference maps of all human cells to describe and define the cellular basis of health and disease.
  • Spatial phenotyping is a critical next step in single-cell biology which can be used to build a comprehensive cell atlas of human tissues.
  • The value of the CODEX platform is to provide unbiased, whole tissue and single-cell imaging, which could greatly contribute towards building a cell atlas and advancing the mission of the Human Cell Atlas initiative, said Brian McKelligon, CEO of Akoya.